Israel Grants Owlytics $1.3M to Develop Wearable AI Device to Improve MS Care
The Israeli Innovation Authority has awarded Owlytics Healthcare a $1.3-million grant to support the company’s development of wearable…
Articles by David Melamed, PhD
MS Patients Report Moderate Health-related Quality of Life, Literature Review Finds
Patients with multiple sclerosis (MS) report moderate scores in mental and physical health, as measured by three, well-established quality-of-life…
MSAA Opens ‘COVID-19 and MS Pathfinder’ Online Informative Platform
The Multiple Sclerosis Association of America (MSAA) teamed with Wondros, a creative production company, to launch COVID-19 and MS…
Higher BMI as Teenagers Raises Risk of MS for Men, Study Finds
Young men, ages 16 to 20, with a higher the body mass index (BMI) are at greater their risk…
PROTXX, University of Alberta Collaborate to Develop Remote Healthcare Platform for MS Patients
The University of Alberta and PROTXX are collaborating to develop wearable sensors for people with multiple sclerosis (MS) and…
Online Resource Center Informs MS Patients About Treatments, Adherence
MyHealthTeams and EMD Serono have teamed up to launch the Treatment and Adherence Resource Center, a new informational…
Walking Patterns of MS Patients Studied to Reduce Risk of Falling
People with multiple sclerosis (MS) exert increased caution with their walking pattern and take smaller steps overall, a study…
Andrographolide Shows Promising Results for Non-active PMS Patients in Trial
Andrographolide, an herbal compound with anti-inflammatory and neuroprotective properties, is able to slow brain atrophy and progression of disability…
MS Patients Invited to Join Dutch Survey Study of Working Life
Researchers at Vrije University Amsterdam in the Netherlands are inviting employed people with multiple sclerosis (MS) to take part in an…
Diets of MS Patients in Spain Seen to Favor Fats, Proteins and Inflammation
A study from Spain found the diet of multiple sclerosis (MS) patients to contain more fat and protein, and fewer…
Phase 2 Trial of Progressive MS Treatment Postponed Due to COVID-19
A planned Phase 2 clinical trial of a potential treatment for progressive multiple sclerosis has been postponed to keep hospital…
MS Patients Find Cannabis Helpful for Easing Pain, Spasticity, Study Reports
About 85% of people with multiple sclerosis (MS) using cannabis find it to be helpful for pain, and…
Virtual Reality Test Can Detect Subtle Balance Issues in MS Patients
A new test involving a virtual reality simulation was able to detect balance issues in patients with multiple sclerosis…
MS Patients Switching from Tysabri to Other Therapies May Risk Disease Activity
Multiple sclerosis (MS) patients switching from Tysabri (natalizumab) to other disease-modifying therapies may have an increased risk of…